CITRATE SALT OF CYCLIN-DEPENDENT KINASE (CDK4/6) INHIBITOR, CRYSTAL FORM THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF

The present invention relates to a citrate salt of a compound of formula (I). The present invention also relates to a crystal form A, a crystal form B, a crystal form C, and a crystal form D of the citrate salt of the compound of formula (I). The present invention also relates to a pharmaceutical co...

Full description

Saved in:
Bibliographic Details
Main Authors ZHU, Shuang, WANG, Kexin, ZHU, Qiaoyou, HUANG, Wenshu, JIN, Meixia, PENG, Yuhui, LIU, Jiuzhi, YU, Jiangtian
Format Patent
LanguageChinese
English
French
Published 04.04.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a citrate salt of a compound of formula (I). The present invention also relates to a crystal form A, a crystal form B, a crystal form C, and a crystal form D of the citrate salt of the compound of formula (I). The present invention also relates to a pharmaceutical composition comprising at least one of the citrate salt of the compound of formula (I) of the present invention, and the crystal form A, the crystal form B, the crystal form C, and the crystal form D of the citrate salt of the compound of formula (I) of the present invention. The present invention also relates to use of the citrate salt of the present invention, the crystal form A, the crystal form B, the crystal form C, and the crystal form D of the citrate salt of the present invention, and the pharmaceutical composition of the present invention in the preparation of a drug for treating, preventing or ameliorating abnormal cell proliferation. The present invention also relates to use of the citrate salt of the pres
Bibliography:Application Number: WO2023CN118429